JP2021520357A5 - - Google Patents
Info
- Publication number
- JP2021520357A5 JP2021520357A5 JP2020554100A JP2020554100A JP2021520357A5 JP 2021520357 A5 JP2021520357 A5 JP 2021520357A5 JP 2020554100 A JP2020554100 A JP 2020554100A JP 2020554100 A JP2020554100 A JP 2020554100A JP 2021520357 A5 JP2021520357 A5 JP 2021520357A5
- Authority
- JP
- Japan
- Prior art keywords
- xrpd pattern
- compound
- crystalline form
- theta
- values
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023147376A JP7663642B2 (ja) | 2018-04-02 | 2023-09-12 | エラミプレチドの合成に有用な結晶性ジペプチド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862651430P | 2018-04-02 | 2018-04-02 | |
| US62/651,430 | 2018-04-02 | ||
| PCT/US2019/024617 WO2019195080A1 (en) | 2018-04-02 | 2019-03-28 | Crystalline dipeptides useful in the synthesis of elamipretide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023147376A Division JP7663642B2 (ja) | 2018-04-02 | 2023-09-12 | エラミプレチドの合成に有用な結晶性ジペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021520357A JP2021520357A (ja) | 2021-08-19 |
| JP2021520357A5 true JP2021520357A5 (https=) | 2022-03-30 |
| JP7350007B2 JP7350007B2 (ja) | 2023-09-25 |
Family
ID=68101313
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554100A Active JP7350007B2 (ja) | 2018-04-02 | 2019-03-28 | エラミプレチドの合成に有用な結晶性ジペプチド |
| JP2023147376A Active JP7663642B2 (ja) | 2018-04-02 | 2023-09-12 | エラミプレチドの合成に有用な結晶性ジペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023147376A Active JP7663642B2 (ja) | 2018-04-02 | 2023-09-12 | エラミプレチドの合成に有用な結晶性ジペプチド |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US10975118B2 (https=) |
| EP (2) | EP4219523A3 (https=) |
| JP (2) | JP7350007B2 (https=) |
| KR (2) | KR20250010134A (https=) |
| CN (2) | CN112292388B (https=) |
| AU (1) | AU2019249121B2 (https=) |
| CA (2) | CA3280578A1 (https=) |
| DK (1) | DK3774844T3 (https=) |
| ES (1) | ES2941266T3 (https=) |
| FI (1) | FI3774844T3 (https=) |
| IL (2) | IL277718B2 (https=) |
| PT (1) | PT3774844T (https=) |
| WO (1) | WO2019195080A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3017359A1 (en) * | 2016-03-11 | 2017-09-14 | Scott M. Duncan | Crystalline salt forms |
| KR20250010134A (ko) | 2018-04-02 | 2025-01-20 | 스텔스 바이오테라퓨틱스 인코포레이티드 | 엘라미프레티드의 합성에 유용한 결정질 디펩티드 |
| CN117881411A (zh) | 2021-06-01 | 2024-04-12 | 艾迪雅生物有限责任公司 | 用于眼部药物的延长释放药物递送系统和使用方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4711166B2 (ja) * | 2004-08-03 | 2011-06-29 | 株式会社 液晶先端技術開発センター | 結晶化装置、および結晶化方法 |
| CA3022250A1 (en) * | 2012-12-12 | 2014-06-12 | Ariad Pharmaceuticals, Inc. | Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride |
| CN108558969A (zh) * | 2014-03-28 | 2018-09-21 | 江苏天士力帝益药业有限公司 | 吡唑衍生物的多晶型物 |
| WO2016001042A1 (en) | 2014-06-30 | 2016-01-07 | Flamma S.P.A. | Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide |
| EP3265109B1 (en) * | 2015-03-06 | 2020-10-21 | Stealth BioTherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
| AU2016272089B2 (en) * | 2015-06-03 | 2021-02-18 | Triastek, Inc. | Dosage forms and use thereof |
| CA3017359A1 (en) * | 2016-03-11 | 2017-09-14 | Scott M. Duncan | Crystalline salt forms |
| EP3500286A4 (en) | 2016-08-16 | 2020-03-25 | Stealth BioTherapeutics Corp | N-CARBOXYANHYDRIDE-BASED SCALE SYNTHESIS OF ELAMIPRETID |
| US11034724B2 (en) * | 2017-04-05 | 2021-06-15 | Stealth Biotherapeutics Corp. | Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2 |
| KR20250010134A (ko) | 2018-04-02 | 2025-01-20 | 스텔스 바이오테라퓨틱스 인코포레이티드 | 엘라미프레티드의 합성에 유용한 결정질 디펩티드 |
-
2019
- 2019-03-28 KR KR1020257000322A patent/KR20250010134A/ko active Pending
- 2019-03-28 EP EP23156906.2A patent/EP4219523A3/en active Pending
- 2019-03-28 PT PT197814320T patent/PT3774844T/pt unknown
- 2019-03-28 AU AU2019249121A patent/AU2019249121B2/en active Active
- 2019-03-28 US US16/485,369 patent/US10975118B2/en active Active
- 2019-03-28 ES ES19781432T patent/ES2941266T3/es active Active
- 2019-03-28 IL IL277718A patent/IL277718B2/en unknown
- 2019-03-28 DK DK19781432.0T patent/DK3774844T3/da active
- 2019-03-28 FI FIEP19781432.0T patent/FI3774844T3/fi active
- 2019-03-28 CA CA3280578A patent/CA3280578A1/en active Pending
- 2019-03-28 IL IL315355A patent/IL315355A/en unknown
- 2019-03-28 CA CA3095869A patent/CA3095869C/en active Active
- 2019-03-28 CN CN201980037029.8A patent/CN112292388B/zh active Active
- 2019-03-28 JP JP2020554100A patent/JP7350007B2/ja active Active
- 2019-03-28 KR KR1020207031595A patent/KR102753323B1/ko active Active
- 2019-03-28 EP EP19781432.0A patent/EP3774844B1/en active Active
- 2019-03-28 CN CN202410219985.0A patent/CN118206614A/zh active Pending
- 2019-03-28 WO PCT/US2019/024617 patent/WO2019195080A1/en not_active Ceased
-
2021
- 2021-04-07 US US17/224,353 patent/US11560404B2/en active Active
-
2022
- 2022-12-21 US US18/086,203 patent/US12018094B2/en active Active
-
2023
- 2023-09-12 JP JP2023147376A patent/JP7663642B2/ja active Active
-
2024
- 2024-05-15 US US18/665,100 patent/US20250122238A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021520357A5 (https=) | ||
| JP2019058014A5 (https=) | ||
| JP2009535462A5 (https=) | ||
| JP2011510079A5 (https=) | ||
| JP2018505199A5 (https=) | ||
| JP2020097737A5 (https=) | ||
| JP2016000739A5 (https=) | ||
| JP2022540353A5 (https=) | ||
| JP2011037885A5 (https=) | ||
| JP2018030858A5 (https=) | ||
| CN114206850A (zh) | 作为crac抑制剂的2h-苯并吡喃衍生物 | |
| JP2023508938A5 (https=) | ||
| JPWO2021220648A5 (https=) | ||
| JP2012246172A5 (https=) | ||
| JP2019512542A5 (https=) | ||
| FI3774844T3 (fi) | Elamipretidin synteesissä hyödyllisiä kiteisiä dipeptidejä | |
| CN111433213A (zh) | 作为Akt抑制剂的盐型及其晶型 | |
| JPWO2019168107A5 (https=) | ||
| JP2022501351A5 (https=) | ||
| JP2007503406A5 (https=) | ||
| JP2023512413A5 (https=) | ||
| RU2005102294A (ru) | Орбитальное зеркало | |
| JPWO2022124344A5 (https=) | ||
| JP2022040937A5 (https=) | ||
| RU2723990C3 (ru) | Кристаллическая форма (s)-n-(5-((r)-2-(2,5-дифторфенил)-пирролидин-1-ил)-пиразоло[1,5-a]пиримидин-3-ил)-3-гидроксипирролидин-1-карбоксамида гидросульфата |